Mesoblastic nephroma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Mesoblastic nephroma}} {{CMG}}; {{AE}} {{SC}} ==Overview== ==References== {{reflist|2}} {{WH}} {{WS}} Category:Disease Category:Types of cancer")
 
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{SC}}
{{CMG}}; {{AE}} {{SC}}
==Overview==
==Overview==
== Differential diagnosis ==
A common differential diagnosis includes the following tumors:
* Mesoblastic nephroma (congenital): from birth to 1 year
* [[Rhabdoid tumor]]: from 1 to 2 years of age
* [[Clear cell sarcoma of the kidney]]: from 2 to 3 years of age.
* [[Wilm's tumor]]: over 3 years of age.
The age breakdown is far from exact, but provides a useful age range and approximate order. Wilm's is most common, accounting for 80-85% of all pediatric kidney tumors. Congenital mesoblastic nephroma accounts for about 10-15%; rhabdoid and CCSK split the remained 5-10%.


==References==
==References==

Revision as of 20:06, 2 November 2015

Mesoblastic nephroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mesoblastic nephroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mesoblastic nephroma differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mesoblastic nephroma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mesoblastic nephroma differential diagnosis

CDC on Mesoblastic nephroma differential diagnosis

Mesoblastic nephroma differential diagnosis in the news

Blogs on Mesoblastic nephroma differential diagnosis

Directions to Hospitals Treating Mesoblastic nephroma

Risk calculators and risk factors for Mesoblastic nephroma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Differential diagnosis

A common differential diagnosis includes the following tumors:

The age breakdown is far from exact, but provides a useful age range and approximate order. Wilm's is most common, accounting for 80-85% of all pediatric kidney tumors. Congenital mesoblastic nephroma accounts for about 10-15%; rhabdoid and CCSK split the remained 5-10%.

References

Template:WH Template:WS